These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 7431656)
41. [Prophylaxis with cefazolin in surgery of the hip (author's transl)]. Piroelle Y; Fraioli F; Roy-Camille R Sem Hop; 1981 Dec 8-15; 57(45-46):1965-9. PubMed ID: 6275539 [TBL] [Abstract][Full Text] [Related]
42. [Cefazolin content in the gall bladder (author's transl)]. Greif S; Forche G; Kratochvil P Wien Klin Wochenschr; 1977 Feb; 89(3):89-90. PubMed ID: 836611 [TBL] [Abstract][Full Text] [Related]
43. [Selection of sputum specimens for the bacteriologic examination according to the microscopic finding (author's transl)]. Kotarski Z Plucne Bolesti Tuberk; 1980; 32(1-2):58-61. PubMed ID: 7403328 [No Abstract] [Full Text] [Related]
44. [Immunofluorescence technique applied at serological diagnosis of the respiratory tract infections from gram-negatives bacteria (author's transl)]. Visconti A Ann Sclavo; 1976; 18(2):322-37. PubMed ID: 797326 [TBL] [Abstract][Full Text] [Related]
45. [Cefazedone-results of a multicentre clinical test (author's transl)]. Koch E; Wiemann H; Empl I MMW Munch Med Wochenschr; 1980 Mar; 122(12):431-4. PubMed ID: 6769007 [TBL] [Abstract][Full Text] [Related]
46. [Numerical assessment of normal oropharyngeal flora, and that of possible origins of bacteria isolated from sputum and from aspirates obtained from the lower respiratory tract by percutaneous transtracheal aspiration (author's transl)]. Okano H; Arai S; Kamata H; Tanimoto H; Hiromori S Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Sep; 15(9):634-41. PubMed ID: 592578 [No Abstract] [Full Text] [Related]
47. Non-invasive biomarkers in exacerbations of obstructive lung disease. Warwick G; Thomas PS; Yates DH Respirology; 2013 Jul; 18(5):874-84. PubMed ID: 23521049 [TBL] [Abstract][Full Text] [Related]
48. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy. Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808 [TBL] [Abstract][Full Text] [Related]
49. [Investigation of cephapirin in treatment of pulmonary infections (author's transl)]. Hara K; Sato A; Nasu M; Nakatomi M; Iwanaga M Jpn J Antibiot; 1974 Apr; 27(2):174-81. PubMed ID: 4546627 [No Abstract] [Full Text] [Related]
50. [Isolation and its significance of organisms in respiratory infections (author's transl)]. Nasu M; Sawatari K; Mochida C; Iori F; Hayashi A; Shigeno Y; Horiuchi N; Nakatomi M; Saito A; Hara K Rinsho Byori; 1979 May; 27(5):367-73. PubMed ID: 491248 [No Abstract] [Full Text] [Related]
51. [Bacterial counts in sputum. The value and interpretation in lower respiratory tract infections (author's transl)]. Chaste A; Level MC; Scavizzi M Rev Fr Mal Respir; 1980; 8(5):393-402. PubMed ID: 7012969 [TBL] [Abstract][Full Text] [Related]
52. [Penetration of cefazolin into bone]. Quentin C; Cantet P; Saux MC; Aran A; Le Rebeller A; Bebear C Therapie; 1985; 40(2):81-5. PubMed ID: 4002194 [No Abstract] [Full Text] [Related]
53. [Use of ceftezol in the field of pneumology: its effectiveness and tolerance]. Giura R; Roccamo B; Donghi M; Scardaccione M; Paddeu A; Bianchi P G Ital Chemioter; 1985; 32(2):337-8. PubMed ID: 3833577 [No Abstract] [Full Text] [Related]
54. [Approach to the crystalline characteristics of ceftezole sodium]. Hu CQ; Cheng SH; Lu L Yao Xue Xue Bao; 2002 Apr; 37(4):275-9. PubMed ID: 12579823 [TBL] [Abstract][Full Text] [Related]
55. [Antibiotic prophylaxis for cardiovascular surgery-a prospective comparison of cefazolin and cephalothin (author's transl)]. Nakada I; Nakamura T; Matsumoto H; Sezaki T; Kobayashi H; Endoh T; Saitoh M; Nanba Y; Yamakawa H Kyobu Geka; 1982; 35(4):292-6. PubMed ID: 7109381 [No Abstract] [Full Text] [Related]
56. [Evaluation of the antibiotic levels in blood and in respiratory secretions in various types of bronchopulmonary infections]. Cía P; Rubio MC; Millastre A; Pacheco G; Civeira Murillo E; Suárez Pinilla MA; Rodrigo G; Sánchez Miret JI; Calderero JL Rev Clin Esp; 1980 Sep; 158(6):289-95. PubMed ID: 7209022 [No Abstract] [Full Text] [Related]
57. [Proteins in the sputum of patients with chronic bronchitis (author's transl)]. Scrobogna S Plucne Bolesti Tuberk; 1976; 28(1-2):36-42. PubMed ID: 1013228 [No Abstract] [Full Text] [Related]
58. [Studies on the shift of cefmetazole into the gastrointestinal tract (author's transl)]. Minamitani M; Hayashi H; Tohma T; Kojima T; Sahashi Y; Terao T Jpn J Antibiot; 1980 Jan; 33(1):10-7. PubMed ID: 6929355 [TBL] [Abstract][Full Text] [Related]
59. [Clinical evaluation of cefatrizine for respiratory infections (author's transl)]. Miyazaki N; Ogushi O; Kajiki A; Takamoto M; Ishibashi T Jpn J Antibiot; 1981 Jun; 34(6):955-8. PubMed ID: 7289044 [No Abstract] [Full Text] [Related]
60. ["Velocef squibb" in the treatment of respiratory and urinary infections (author's transl)]. Gómez Francisco A Folia Clin Int (Barc); 1973 Sep; 23(9):616-21. PubMed ID: 4616857 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]